electroCore Inc (ECOR): Market Cap to Revenue

Symbol and logo of brand electroCore Medical (ECOR)

High trust from physicians and patients regarding the safety of gammaCore systems strengthens the brand position of electroCore, Inc. (ECOR). The company's industry-average P/S reflects valuation dynamics, where 1.30 captures the current state of the parameter. Stable revenue is driven by digital subscriptions for migraine therapy, while diversification into non-drug treatments for asthma and anxiety minimizes the business's operational risks.

ECOR electroCore Medical P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for electroCore, Inc. (ECOR)

- share price and consensus valuation forecast:
Price Performance Chart electrocore.com|ECOR - Price Target Chart
- stock exchange capitalization data:
Market Valuation electroCore Medical|ECOR - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share electroCore|ECOR - Book Capitalization|Capitalization to Book Value Ratio electrocore.com|ECOR - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient electroCore, Inc.|ECOR - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio electrocore.com|ECOR - Company Aggregate Debts|Debts to Book Capitalization electroCore Medical|ECOR - Company Long-Term Debt|Company Short-Term Debt electroCore|Intermediate Coverage Ratio electrocore.com
- earnings and multiples data:
ECOR - Net Profit|Expected Net Profit electroCore, Inc.|ECOR - Price to Earnings Ratio|Forward Price to Earnings Multiple electrocore.com|ECOR - Price/Earnings to Growth Multiple|EV/EBITDA Multiple electroCore Medical|ECOR - Operating profit EBITDA|Net earnings per share for the last four quarters electroCore|ECOR - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months electrocore.com|ECOR - Earnings per share growth in current year|Expected earnings per share growth for next year electroCore, Inc.
- issuer revenue and sales details:
ECOR - Revenue and Sales Volume|Company Expected Sales Volume electrocore.com|ECOR - Price-to-Revenue Ratio|Market Cap to Projected Revenue electroCore Medical
General company analysis:ECOR electroCore Inc
Core merchandise of electroCore

For electroCore, Inc. (ECOR), the correlation between market value and actual sales of nerve stimulation systems determines its investment attractiveness. The P/S ratio measures the cost of one dollar of revenue, reflecting the market's level of optimism regarding future earnings. By analyzing the current price-to-sales ratio, an investor can see how diversifying distribution through US clinics and pharmacies impacts the business valuation. Low indicator values may signal that the asset is undervalued.

Competitors of electroCore, Inc.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA: P/S Multiple|Price to Sales STRATA Skin Sciences, Inc. (SSKN)|Price-to-Revenue Ratio GlucoTrack, Inc.|Price-to-Revenue Ratio NAOV|P/S Multiple VERO|NUWE - Price to Sales|P/S Multiple AEMD (Aethlon Medical)|ASXC - Market Cap to Revenue|AVGR: Market Cap to Revenue|BioSig - Market Cap to Sales Volume|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|Know Labs Corporation - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Inari Medical, Inc.|Price to Sales nevro.com NVRO|P/S Multiple RSLS|Market Cap to Revenue Silk Road Medical, Inc. SILK